Brightspring Health Services Inc Revenue Growth Rates (BTSG), Current and Historic Growth - CSIMarket
CSIMarket
 


Brightspring Health Services Inc   (NASDAQ: BTSG)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

BTSG's Revenue Growth by Quarter and Year

Brightspring Health Services Inc 's Revenue results by quarter and year




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/BTSG/growth
https://api.csimarket.com/api/v1/companies/BTSG/fundamentals
https://api.csimarket.com/api/v1/companies/BTSG/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
BTSG Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 4,213.23
2nd Quarter June 3,873.14
1st Quarter March 742.22
FY 8,828.59





BTSG Revenue third quarter 2026 Y/Y Growth Comment
Brightspring Health Services Inc achieved in the third quarter 2026, above Company average Revenue surge of 588.43% year on year, to $ 4,213.23 millions.

Looking into third quarter 2026 results within Healthcare Facilities industry 31 other companies have achieved higher Revenue growth. While Brightspring Health Services Inc ' s Revenue doubling of 588.43% ranks overall at the positon no. 2914 in the third quarter 2026.




BTSG Revenue ( Y/Y Growth %) 2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 588.43 %
2nd Quarter June 555.52 %
1st Quarter March 35.1 %
FY   -

Financial Statements
Brightspring Health Services Inc 's third quarter 2026 Revenue $ 4,213.23 millions BTSG's Income Statement
Brightspring Health Services Inc 's third quarter 2025 Revenue $ 612.01 millions Quarterly BTSG's Income Statement


BTSG Revenue (Quarter on Quarter Growth %)

2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 8.78 %
2nd Quarter June 421.83 %
1st Quarter March 14.09 %
FY (Year on Year)   -




Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #32
Healthcare Sector #402
Overall #2914

Revenue Y/Y Growth Statistics
High Average Low
107.68 % -9.68 % -52.78 %
(Jun 30 2026)   (Mar 31 2025)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #32
Healthcare Sector #402
Overall #2914
Revenue Y/Y Growth Statistics
High Average Low
107.68 % -9.68 % -52.78 %
(Jun 30 2026)   (Mar 31 2025)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Brightspring Health Services Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
421.83 % 27.43 % -45.08 %
(Jun 30 2026)  


BTSG's III. Quarter Q/Q Revenue Comment
Brightspring Health Services Inc achieved in the III. Quarter 2026 below company average Revenue increase of 8.78% quarter on quarter, to $ 4,213.23 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 3.58% in the III. Quarter a year ago.

Within Healthcare Facilities industry Brightspring Health Services Inc achieved highest sequential Revenue growth. While Brightspring Health Services Inc 's Revenue growth quarter on quarter, overall rank is 54.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #0
Healthcare Sector #20
Overall #54
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #0
Healthcare Sector #20
Overall #54
Revenue Q/Q Growth Statistics
High Average Low
421.83 % 27.43 % -45.08 %
(Jun 30 2026)  


BTSG's III. Quarter Q/Q Revenue Comment
Brightspring Health Services Inc achieved in the III. Quarter 2026 below company average Revenue increase of 8.78% quarter on quarter, to $ 4,213.23 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 3.58% in the III. Quarter a year ago.

Within Healthcare Facilities industry Brightspring Health Services Inc achieved highest sequential Revenue growth. While Brightspring Health Services Inc 's Revenue growth quarter on quarter, overall rank is 54.


Brightspring Health Services Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)
12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 9,479.14
Y / Y Revenue Growth (TTM) 262.75 %
Year on Year Revenue Growth Overall Ranking # 3610
Seqeuential Revenue Change (TTM) 61.27 %
Seq. Revenue Growth (TTM) Overall Ranking # 3090


Cumulative Revenue growth Comment
Brightspring Health Services Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 262.75% year on year, to $ 9,479 millions if the fiscal year would have ended in Sep 30 2026.
Brightspring Health Services Inc 's trailing twelve months Revenue growth was higher than company's average -16.54% and higher than 107.68% growth in Jun 30 2026.
But from twelve months ended Jun 30 2026 rise was beneth at 61.27 % from $5877.92 millions achieved in the period from Jun 30 2026 to Sep 30 2025.
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at -16.54%.

In the Healthcare sector 491 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2776 to 3610.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 34
Healthcare Sector # 492
Overall # 3610

Revenue TTM Y/Y Growth Statistics
High Average Low
107.68 %
-16.54 %
-57.65 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 34
Sector # 418
S&P 500 # 3090
Cumulative Revenue growth Comment
Brightspring Health Services Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 262.75% year on year, to $ 9,479 millions if the fiscal year would have ended in Sep 30 2026.
Brightspring Health Services Inc 's trailing twelve months Revenue growth was higher than company's average -16.54% and higher than 107.68% growth in Jun 30 2026.
But from twelve months ended Jun 30 2026 rise was beneth at 61.27 % from $5877.92 millions achieved in the period from Jun 30 2026 to Sep 30 2025.
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at -16.54%.
The momentum is even more impressive from twelve months ended Jun 30 2026 exhibited at 61.27 % increase from $5877.92 millions in the period from Jun 30 2026 to Sep 30 2025.

In the Healthcare sector 491 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2776 to 3610.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 34
Healthcare Sector # 492
Overall # 3610

Revenue TTM Y/Y Growth Statistics
High Average Low
107.68 %
-16.54 %
-57.65 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 34
Sector # 418
S&P 500 # 3090




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BTSG's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Ibio inc 975.00%$ 975.000 millions
Sintx Technologies Inc 952.88%$ 952.885 millions
Foghorn Therapeutics Inc 924.69%$ 924.690 millions
Nrx Pharmaceuticals Inc 874.79%$ 874.793 millions
Zymeworks Inc 828.73%$ 828.732 millions
Pmgc Holdings Inc 784.90%$ 784.904 millions
Onemednet Corporation731.71%$ 731.707 millions
Catheter Precision Inc 713.27%$ 713.274 millions
Abeona Therapeutics Inc 706.88%$ 706.878 millions
Brightspring Health Services Inc 588.43%$ 588.428 millions
Hcw Biologics Inc 583.54%$ 583.538 millions
Bio Green Med Solution Inc 460.49%$ 460.494 millions
Xencor Inc454.88%$ 454.884 millions
Tonix Pharmaceuticals Holding Corp 423.83%$ 423.830 millions
Nakamoto Inc 396.90%$ 396.897 millions
EBR Systems, Inc.385.65%$ 385.647 millions
Solana Company382.07%$ 382.066 millions
Pulse Biosciences Inc 359.30%$ 359.302 millions
Ensysce Biosciences Inc 342.43%$ 342.428 millions
Northwest Biotherapeutics Inc341.50%$ 341.500 millions
Nexalin Technology Inc 331.43%$ 331.434 millions
Agios Pharmaceuticals Inc 330.01%$ 330.008 millions
Insmed Inc330.00%$ 330.000 millions
Monte Rosa Therapeutics Inc 325.80%$ 325.799 millions
Liquidia Corporation314.60%$ 314.596 millions
Stablecoin Development Corporation310.75%$ 310.749 millions
Renovorx Inc 300.75%$ 300.752 millions


About Brightspring Health Services Inc Revenue Growth Rates (BTSG), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Brightspring Health Services Inc (CIK 1865782).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001865782-26-000012
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Brightspring Health Services Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.